Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Update on consensus arylamine N-acetyltransferase gene nomenclature.

Literature DB >> 10862519

Update on consensus arylamine N-acetyltransferase gene nomenclature.

D W Hein, D M Grant, E Sim.

Abstract

Mesh：

Substances：

Year: 2000 PMID： 10862519 DOI： 10.1097/00008571-200006000-00002

Source DB: PubMed Journal: Pharmacogenetics ISSN： 0960-314X

Keyword Cloud
Cited

× No keyword cloud information.

29 in total

1. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.

Authors: C Deloménie; S Fouix; S Longuemaux; N Brahimi; C Bizet; B Picard; E Denamur; J M Dupret
Journal: J Bacteriol Date: 2001-06 Impact factor: 3.490

2. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Authors: Montserrat García-Closas; Núria Malats; Debra Silverman; Mustafa Dosemeci; Manolis Kogevinas; David W Hein; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Josep Lloreta; Gemma Castaño-Vinyals; Meredith Yeager; Robert Welch; Stephen Chanock; Nilanjan Chatterjee; Sholom Wacholder; Claudine Samanic; Montserrat Torà; Francisco Fernández; Francisco X Real; Nathaniel Rothman
Journal: Lancet Date: 2005 Aug 20-26 Impact factor: 79.321

3. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Authors: L E Moore; D R Baris; J D Figueroa; M Garcia-Closas; M R Karagas; M R Schwenn; A T Johnson; J H Lubin; D W Hein; C L Dagnall; J S Colt; M Kida; M A Jones; A R Schned; S S Cherala; S J Chanock; K P Cantor; D T Silverman; N Rothman
Journal: Carcinogenesis Date: 2010-10-29 Impact factor: 4.944

4. Re-assessment of the influence of polymorphisms of phase-II metabolic enzymes on renal cell cancer risk of trichloroethylene-exposed workers.

Authors: Bernd Wiesenhütter; Silvia Selinski; Klaus Golka; Thomas Brüning; Hermann M Bolt
Journal: Int Arch Occup Environ Health Date: 2007-05-04 Impact factor: 3.015

10. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.

Authors: M D Crabtree; C Fletcher; M Churchman; S V Hodgson; K Neale; R K S Phillips; I P M Tomlinson
Journal: Gut Date: 2004-02 Impact factor: 23.059

Update on consensus arylamine N-acetyltransferase gene nomenclature.

1. Identification and functional characterization of arylamine N-acetyltransferases in eubacteria: evidence for highly selective acetylation of 5-aminosalicylic acid.

2. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

3. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

4. Re-assessment of the influence of polymorphisms of phase-II metabolic enzymes on renal cell cancer risk of trichloroethylene-exposed workers.

Review 5. A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.

6. Relationship between N-acetyltransferase 2 single-nucleotide polymorphisms and phenotype.

7. Effect of acetaminophen on sulfamethazine acetylation in male volunteers.

8. Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk.

9. Ocular defects associated with a null mutation in the mouse arylamine N-acetyltransferase 2 gene.

10. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.